I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
Ron Johnson emphasizes the importance of profitability in drug development amidst healthcare spending discussions.
Share
More from Ron Johnson
This is going to take time, but when my staff saw this, I mean, to me, this immediately impacts public safety, immediately impacts informed consent.
I mean, that is shocking, and they knew it. They knew it, they're not that stupid. They're just that devious to play with the statistics that way to misinform, to lie to the American public.
So the proper percentage is 104 divided by 127, an 82% miscarriage rate with women who got the injection in the first second trimester.
Other voices in this conversation
